OR WAIT null SECS
April 14, 2023
Avid Bioservices has launched new CGMP mammalian cell manufacturing suites at its Myford, Calif., facility.
FDA has granted fast track designation to Caribou Biosciences for its allogeneic CAR-T cell therapy for relapsed or refractory multiple myeloma.
Under this partnership, the two companies will develop bioprinted tissue therapeutics for diabetes and obesity.
The construction will expand Catalent’s clinical supply facility in Schorndorf, Germany.
Ginkgo Bioworks has acquired StrideBio's AAV capsid discovery and engineering platform and has formed a partnership with WARF for development of next-gen cell therapies.
The acquisition of Cell Systems will bolster AnaBios’ portfolio of human tissue and cells for use in drug discovery.
April 12, 2023
Forecyte Bio has opened a new GMP facility in Shanghai just two months after its sister site in the United States.
The new site will include state-of-the-art cleanroom facilities, laboratories, R&D, and office spaces.
The decision was issued in a joint statement by the FDA Commissioner and Chief Scientist, and effective on April 11.
The BalanCD CHO media portfolio is designed to ensure maximized growth, viability, and productivity of CHO cell lines.
